Invention Grant
- Patent Title: Formulation of human antibodies for treating TNF-alpha associated disorders
-
Application No.: US14091938Application Date: 2013-11-27
-
Publication No.: US08795670B2Publication Date: 2014-08-05
- Inventor: Hans-Juergen Krause , Lisa Baust , Michael Dickes
- Applicant: Abbvie Biotechnology Ltd.
- Applicant Address: BM Hamilton
- Assignee: AbbVie Biotechnology Ltd.
- Current Assignee: AbbVie Biotechnology Ltd.
- Current Assignee Address: BM Hamilton
- Agency: Rope & Gray LLP
- Agent James F. Haley, Jr.; Z. Ying Li
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/24 ; C07K14/525 ; A61K47/26 ; A61K47/10 ; A61K9/00 ; A61K47/18 ; A61K47/12 ; A61K9/19 ; A61K47/22
Abstract:
A liquid aqueous pharmaceutical formulation is described which has a high protein concentration, a pH of between about 4 and about 8, and enhanced stability.
Public/Granted literature
- US20140086931A1 FORMULATION OF HUMAN ANTIBODIES FOR TREATING TNF-ALPHA ASSOCIATED DISORDERS Public/Granted day:2014-03-27
Information query
